CN105853726A - 一种皮肤舒缓液的制备方法 - Google Patents
一种皮肤舒缓液的制备方法 Download PDFInfo
- Publication number
- CN105853726A CN105853726A CN201610203286.2A CN201610203286A CN105853726A CN 105853726 A CN105853726 A CN 105853726A CN 201610203286 A CN201610203286 A CN 201610203286A CN 105853726 A CN105853726 A CN 105853726A
- Authority
- CN
- China
- Prior art keywords
- parts
- skin
- liquid
- preparation
- releived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 56
- 239000012141 concentrate Substances 0.000 claims abstract description 25
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 239000011347 resin Substances 0.000 claims abstract description 17
- 229920005989 resin Polymers 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001061264 Astragalus Species 0.000 claims abstract description 9
- 241001313855 Bletilla Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 9
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 9
- 244000136948 Ocimum sanctum Species 0.000 claims abstract description 9
- 235000004072 Ocimum sanctum Nutrition 0.000 claims abstract description 9
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 9
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims abstract description 9
- 244000022370 Symplocos paniculata Species 0.000 claims abstract description 9
- 235000003337 Symplocos paniculata Nutrition 0.000 claims abstract description 9
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- 235000006533 astragalus Nutrition 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 210000004233 talus Anatomy 0.000 claims abstract description 9
- 239000011975 tartaric acid Substances 0.000 claims abstract description 9
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000011787 zinc oxide Substances 0.000 claims abstract description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 8
- 229960001631 carbomer Drugs 0.000 claims abstract description 8
- 241001529821 Agastache Species 0.000 claims abstract description 3
- 241001116389 Aloe Species 0.000 claims description 32
- 235000011399 aloe vera Nutrition 0.000 claims description 32
- 238000002360 preparation method Methods 0.000 claims description 28
- 239000012466 permeate Substances 0.000 claims description 17
- 230000002745 absorbent Effects 0.000 claims description 16
- 239000002250 absorbent Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 244000144725 Amygdalus communis Species 0.000 claims description 8
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 8
- 244000178870 Lavandula angustifolia Species 0.000 claims description 8
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 8
- 244000042664 Matricaria chamomilla Species 0.000 claims description 8
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 8
- 235000008326 Trichosanthes anguina Nutrition 0.000 claims description 8
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 8
- 235000020224 almond Nutrition 0.000 claims description 8
- 239000000084 colloidal system Substances 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 239000001102 lavandula vera Substances 0.000 claims description 8
- 235000018219 lavender Nutrition 0.000 claims description 8
- 238000003809 water extraction Methods 0.000 claims description 8
- 239000000341 volatile oil Substances 0.000 claims description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 4
- 229940083466 soybean lecithin Drugs 0.000 claims description 4
- 240000002045 Guettarda speciosa Species 0.000 claims 1
- 244000061520 Angelica archangelica Species 0.000 abstract description 8
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 238000001179 sorption measurement Methods 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 239000013566 allergen Substances 0.000 abstract 1
- -1 aloe extract Substances 0.000 abstract 1
- 229940069521 aloe extract Drugs 0.000 abstract 1
- 235000019480 chamomile oil Nutrition 0.000 abstract 1
- 239000010628 chamomile oil Substances 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 abstract 1
- 238000002386 leaching Methods 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 229960001367 tartaric acid Drugs 0.000 abstract 1
- 229960001296 zinc oxide Drugs 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 19
- 241000196324 Embryophyta Species 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000000172 allergic effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000005551 L01XE03 - Erlotinib Substances 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 3
- 229960001433 erlotinib Drugs 0.000 description 3
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种皮肤舒缓液的制备方法,先取黄耆、当归、白芍药、白芷、川芎、藿香叶、零陵香、白檀、白附子、白及、白蔹、瓜蒌、杏仁、龙脑混合,得到混合物,粉碎,加入水中浸提,将所得提取液浓缩,再将浓缩液送入大孔吸附树脂中进行吸附,得到透过液,最后将透过液、薰衣草精油、洋甘菊精油、芦荟提取液、果酸、氧化锌、维生素E、卡波姆、甘油混合,即可。本发明的皮肤舒缓液能改善皮肤微血管循环,消炎止痒,促进皮肤新陈代替,从而抑制和消除致敏源,舒缓过敏反应。
Description
技术领域
本发明属于中药制剂技术领域,具体涉及一种皮肤舒缓液的制备方法。
背景技术
皮肤遇到某种刺激,常发生骚痒、红肿、刺痛等过敏反应,尤其过敏体质的人群,更常发生此等过敏反应,虽不算什么疾病,但常令人难以忍受,苦不堪言。目前,用于皮肤过敏反应的治疗主要是皮质激素类药物,主要作用是抑制人体的免疫反应,它不仅抑制引起过敏的异常免疫反应,还会抑制正常的免疫反应,降低皮肤细胞的抵抗力,从而诱发非过敏性皮炎,皮肤瘤,诱发黑色素沉积,皮肤异常生长等不良反应,如果长期应用,还会产生药物依赖性。近年来国内外有研究发现,一些植物的浸提物,对皮肤过敏有缓解作用,但是多多少少都存在一些问题,比如提取过程复杂、抗过敏功效单一或有的提取物抗过敏同时又带来其它副作用等。因此,寻找一种可代替当前皮肤抗过敏常用药-皮质激素类药物,且来源于天然植物提取物、抗过敏效果优良的皮肤舒敏药物成为亟待解决问题。
发明内容
本发明的目的是克服现有技术的不足而提供一种皮肤舒缓液的制备方法,所得皮肤舒缓液能改善皮肤微血管循环,消炎止痒,促进皮肤新陈代替,从而抑制和消除致敏源,舒缓过敏反应。
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆3~9份、当归2~8份、白芍药1~7份、白芷2~7份、川芎3~6份、藿香叶1~6份、零陵香2~8份、白檀3~7份、白附子2~7份、白及3~9份、白蔹2~8份、瓜蒌1~5份、杏仁2~6份、龙脑3~8份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液10~20份、薰衣草精油2~5份、洋甘菊精油1~4份、芦荟提取液2~6份、果酸1~4份、氧化锌3~5份、维生素E 2~5份、卡波姆1~5份、甘油2~6份混合,即可。
进一步地,步骤1中加水量是混合物重量的5~10倍。
进一步地,步骤1中浸提的温度是60~80℃。
进一步地,步骤1中浸提的时间是0.5~1小时。
进一步地,步骤2中的浓缩步骤中,使提取液的体积减少至1/3。
进一步地,步骤3中的大孔吸附树脂是D101。
进一步地,步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
进一步地,步骤1所得提取液中还需要加入柠檬酸使其pH在4.0~6.0之间。
进一步地,步骤4中还需要加入大豆卵磷脂1~4份。
本发明的皮肤舒缓液能改善皮肤微血管循环,消炎止痒,促进皮肤新陈代替,从而抑制和消除致敏源,舒缓过敏反应。
具体实施方式
实施例1
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆3份、当归2份、白芍药1份、白芷2份、川芎3份、藿香叶1份、零陵香2份、白檀3份、白附子2份、白及3份、白蔹2份、瓜蒌1份、杏仁2份、龙脑3份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液10份、薰衣草精油2份、洋甘菊精油1份、芦荟提取液2份、果酸1份、氧化锌3份、维生素E 2份、卡波姆1份、甘油2份混合,即可。
其中,步骤1中加水量是混合物重量的5倍,浸提的温度是60℃,浸提的时间是1小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
实施例2
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆7份、当归6份、白芍药2份、白芷6份、川芎5份、藿香叶3份、零陵香6份、白檀5份、白附子4份、白及7份、白蔹5份、瓜蒌3份、杏仁4份、龙脑6份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液17份、薰衣草精油4份、洋甘菊精油2份、芦荟提取液4份、果酸2份、氧化锌4份、维生素E 3份、卡波姆3份、甘油5份混合,即可。
其中,步骤1中加水量是混合物重量的8倍,浸提的温度是70℃,浸提的时间是0.5小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
实施例3
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆8份、当归3份、白芍药5份、白芷4份、川芎5份、藿香叶4份、零陵香7份、白檀5份、白附子5份、白及8份、白蔹7份、瓜蒌2份、杏仁5份、龙脑8份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液15份、薰衣草精油4份、洋甘菊精油3份、芦荟提取液5份、果酸2份、氧化锌4份、维生素E 4份、卡波姆3份、甘油5份混合,即可。
其中,步骤1中加水量是混合物重量的5倍,浸提的温度是60℃,浸提的时间是1小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
实施例4
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆9份、当归8份、白芍药7份、白芷7份、川芎6份、藿香叶6份、零陵香8份、白檀7份、白附子7份、白及9份、白蔹8份、瓜蒌5份、杏仁6份、龙脑8份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液20份、薰衣草精油5份、洋甘菊精油4份、芦荟提取液6份、果酸4份、氧化锌5份、维生素E 5份、卡波姆5份、甘油6份混合,即可。
其中,步骤1中加水量是混合物重量的5倍,浸提的温度是60℃,浸提的时间是1小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
实施例5
本实施例与实施例3的区别在于:步骤1所得提取液中还需要加入柠檬酸使其pH在4.0~6.0之间。
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆8份、当归3份、白芍药5份、白芷4份、川芎5份、藿香叶4份、零陵香7份、白檀5份、白附子5份、白及8份、白蔹7份、瓜蒌2份、杏仁5份、龙脑8份混合,得到混合物,粉碎,加入水中浸提,得到提取液,加入柠檬酸使其pH在4.0;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液15份、薰衣草精油4份、洋甘菊精油3份、芦荟提取液5份、果酸2份、氧化锌4份、维生素E 4份、卡波姆3份、甘油5份混合,即可。
其中,步骤1中加水量是混合物重量的5倍,浸提的温度是60℃,浸提的时间是1小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
实施例6
本实施例与实施例5的区别在于:步骤4中还需要加入大豆卵磷脂1~4份。
一种皮肤舒缓液的制备方法,包括以下步骤:
步骤1,以重量份计,取黄耆8份、当归3份、白芍药5份、白芷4份、川芎5份、藿香叶4份、零陵香7份、白檀5份、白附子5份、白及8份、白蔹7份、瓜蒌2份、杏仁5份、龙脑8份混合,得到混合物,粉碎,加入水中浸提,得到提取液,加入柠檬酸使其pH在4.0;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液15份、薰衣草精油4份、洋甘菊精油3份、芦荟提取液5份、果酸2份、氧化锌4份、维生素E 4份、卡波姆3份、甘油5份、大豆卵磷脂1份混合,即可。
其中,步骤1中加水量是混合物重量的5倍,浸提的温度是60℃,浸提的时间是1小时;步骤2中的浓缩步骤中,使提取液的体积减少至1/3;步骤3中的大孔吸附树脂是D101;步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
选取700名皮肤过敏者参与试用实施例1至6所得舒缓液,并以市售皮质激素作为对照,每组100名,考察连续使用7天后的皮肤改善情况。皮肤过敏症状为面部红肿、瘙痒、脱皮、干燥、疼痛。结果如下:
由上表结果可知,本发明的皮肤舒缓液能显著改善皮肤过敏者面部红肿、瘙痒、脱皮、干燥、疼痛的症状,且效果优于市售皮质激素。实施例5中在步骤1所得提取液中加入柠檬酸使其pH在4.0~6.0之间,使得透过液中有效成分浓度有所提高,所得舒缓液的效果更好;实施例6中由于加入大豆卵磷脂,使得舒缓液中有效成分更加稳定,所得舒缓液的效果更好。
Claims (9)
1.一种皮肤舒缓液的制备方法,其特征在于:包括以下步骤:
步骤1,以重量份计,取黄耆3~9份、当归2~8份、白芍药1~7份、白芷2~7份、川芎3~6份、藿香叶1~6份、零陵香2~8份、白檀3~7份、白附子2~7份、白及3~9份、白蔹2~8份、瓜蒌1~5份、杏仁2~6份、龙脑3~8份混合,得到混合物,粉碎,加入水中浸提,得到提取液;
步骤2,将步骤1所得提取液浓缩,得到浓缩液;
步骤3,将步骤2所得浓缩液送入大孔吸附树脂中进行吸附,得到透过液;
步骤4,以重量份计,将步骤3所得透过液10~20份、薰衣草精油2~5份、洋甘菊精油1~4份、芦荟提取液2~6份、果酸1~4份、氧化锌3~5份、维生素E 2~5份、卡波姆1~5份、甘油2~6份混合,即可。
2.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤1中加水量是混合物重量的5~10倍。
3.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤1中浸提的温度是60~80℃。
4.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤1中浸提的时间是0.5~1小时。
5.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤2中的浓缩步骤中,使提取液的体积减少至1/3。
6.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤3中的大孔吸附树脂是D101。
7.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤4中的芦荟提取液的制备方法是:芦荟去皮,将内部胶质榨汁,得到芦荟提取液。
8.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤1所得提取液中还需要加入柠檬酸使其pH在4.0~6.0之间。
9.根据权利要求1所述的皮肤舒缓液的制备方法,其特征在于:步骤4中还需要加入大豆卵磷脂1~4份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610203286.2A CN105853726A (zh) | 2016-03-31 | 2016-03-31 | 一种皮肤舒缓液的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610203286.2A CN105853726A (zh) | 2016-03-31 | 2016-03-31 | 一种皮肤舒缓液的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105853726A true CN105853726A (zh) | 2016-08-17 |
Family
ID=56627963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610203286.2A Withdrawn CN105853726A (zh) | 2016-03-31 | 2016-03-31 | 一种皮肤舒缓液的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105853726A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107510773A (zh) * | 2017-09-05 | 2017-12-26 | 肇庆高新区国专科技有限公司 | 一种纯植物提取液及其制备方法 |
CN107519372A (zh) * | 2017-09-05 | 2017-12-29 | 肇庆高新区国专科技有限公司 | 一种具有抗过敏、止痕痒的植物提取液及其制备方法 |
CN108703905A (zh) * | 2018-07-17 | 2018-10-26 | 茗尚品牌管理(上海)有限公司 | 一种皮肤舒缓液及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512348A (zh) * | 2012-01-10 | 2012-06-27 | 袁霞 | 一种中药美容面霜 |
-
2016
- 2016-03-31 CN CN201610203286.2A patent/CN105853726A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512348A (zh) * | 2012-01-10 | 2012-06-27 | 袁霞 | 一种中药美容面霜 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107510773A (zh) * | 2017-09-05 | 2017-12-26 | 肇庆高新区国专科技有限公司 | 一种纯植物提取液及其制备方法 |
CN107519372A (zh) * | 2017-09-05 | 2017-12-29 | 肇庆高新区国专科技有限公司 | 一种具有抗过敏、止痕痒的植物提取液及其制备方法 |
CN108703905A (zh) * | 2018-07-17 | 2018-10-26 | 茗尚品牌管理(上海)有限公司 | 一种皮肤舒缓液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107951966B (zh) | 一种中藏药结合的浴足液 | |
US7205009B2 (en) | Composition for treating hair and scalp and method for preparing same | |
CN103041042B (zh) | 一种藏药组合物及其在防脱生发产品中的应用 | |
US20180369308A1 (en) | Chinese herbal medicine composition having a function of relieving hypothyroidism, preparation method and use thereof | |
CN105853726A (zh) | 一种皮肤舒缓液的制备方法 | |
CN107050410B (zh) | 一种中药组合物及其制剂方法和应用 | |
CN103169787B (zh) | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 | |
CN103751530A (zh) | 一种具有抗敏功效的中药组合物的提取物及其应用 | |
CN104306732B (zh) | 一种金斛软胶囊及其制备方法 | |
CN102940715A (zh) | 三七软膏及其制备方法 | |
CN103142848B (zh) | 一种抗衰老中药制剂及其制备方法 | |
CN104352616A (zh) | 治疗坐骨神经痛的中药组合物及其制备方法 | |
CN101700336A (zh) | 一种治疗颅脑外伤后遗性头痛的中药制剂及其制备方法 | |
CN101305803A (zh) | 缓解人体疲劳的保健品及其生产方法 | |
CN102488795A (zh) | 治疗头颈部放疗后放射性皮炎的药物 | |
CN102512539A (zh) | 以人参为主药用于治疗脱发的复方外用搽剂及制备方法 | |
CN105381289A (zh) | 一种治疗月经不调的药物组合物 | |
CN100488543C (zh) | 大蒜局部外用止痒涂剂 | |
CN105853290A (zh) | 一种皮肤纾敏液及其制备方法 | |
CN104013728B (zh) | 一种综合治疗带状疱疹的中药制剂及其制备方法 | |
CN103239646B (zh) | 一种用于治疗白癜风的中药有效部位组合物及其制备方法 | |
CN103432204B (zh) | 一种用于治疗精神分裂症的中药有效部位组合物及其制备方法 | |
CN103006996B (zh) | 一种治疗急进性高血压的药物 | |
CN105935439B (zh) | 具有温肺降浊功效的中药及其制备方法和应用 | |
CN104815073A (zh) | 一种沉香苦丁茶及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160817 |